![]() |
市场调查报告书
商品编码
1880393
单切口腹腔镜手术器械市场预测至2032年:按产品类型、应用、最终用户和地区分類的全球分析Single-Port Laparoscopic Surgery Devices Market Forecasts to 2032 - Global Analysis By Product Type, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球单切口腹腔镜手术器械市场价值将达到 9.224 亿美元,到 2032 年将达到 18.6726 亿美元,预测期内复合年增长率为 10.6%。
单孔腹腔镜手术器械是一种先进的微创手术设备,只需在腹部(通常位于肚脐附近)做一个小切口即可完成手术。它们整合了成像系统、通路和多功能器械,使外科医生能够在腹腔内有效地进行操作。单孔设计可减少创伤、疼痛和疤痕,并加速术后恢復,使外科医生能够以可控且高效的方式完成复杂的手术。
慢性病发生率呈上升趋势
医疗机构正越来越多地采用微创方法,例如单孔腹腔镜手术(SPLS),以微创方式治疗复杂的疾病。诊断影像技术的进步和早期检测的普及扩大了适合手术的患者群体。已开发国家和新兴国家人口老化进一步加剧了对高效手术设备的需求。机器人辅助的单孔腹腔镜手术系统提高了手术精度,减少了併发症,并缩短了恢復时间。个人化医疗的趋势也在推动针对患者独特需求而客製化的专用腹腔镜器械的问世。
缺乏标准化程序和数据
不同医院和地区间技术水平的差异导致患者治疗效果不一致。缺乏单孔腹腔镜手术的全面长期数据,导致临床应用和医保核准延迟。外科医生培训要求仍然很高,增加了操作复杂性,限制了扩充性。小规模医疗设备製造商在缺乏可靠的临床证据或标准化指南的情况下,难以建立信誉。这些因素共同阻碍了单孔腹腔镜手术技术的市场渗透,并减缓了创新步伐。
扩充机器人辅助SPLS
与传统腹腔镜器械相比,先进的机器人系统具有更高的操控性、更佳的视野和更精准的操作。医院正日益增加对机器人辅助单孔腹腔镜手术(SPLS)的投资,以改善手术效果并缩短手术时间。将机器人技术与单孔入路结合,可最大限度地减少疤痕并加快患者康復。随着医疗基础设施的现代化和手术量的成长,新兴市场正越来越多地采用机器人辅助SPLS。机器人技术、人工智慧和诊断成像技术的持续研发可望大幅拓展SPLS的应用范围。
其他微创手术技术
单孔腹腔镜手术(SPLS)面临其他微创手术方式的竞争,例如多孔腹腔镜手术和经自然腔道内视镜手术(NOTES)。这些替代技术通常被认为更为成熟,并拥有充足的临床数据来支持其应用。如果现有技术已取得令人满意的结果,医院可能不愿意投资SPLS设备。成本也是一个考虑因素,因为SPLS系统的实施成本可能更高。患者的偏好以及外科医生对传统腹腔镜手术的熟悉程度也进一步限制了SPLS的广泛应用。
疫情扰乱了全球外科手术的正常进行,导致择期手术推迟,对单点雷射手术(SPLS)设备的需求下降。生产和供应链的中断造成了关键手术设备的短缺。然而,这场危机加速了数位化进程,医院开始探索远端手术平台和远距离诊断。紧急监管核准确保了即使在尖峰时段,也能获得必要的手术工具。后疫情时代的策略强调韧性、自动化和分散式生产,以应对未来的衝击。
预计在预测期内,普通外科手术将占据最大的市场份额。
由于其在盲肠切除手术、疝气修补术和胆囊切除术等多种手术中的应用,普通外科领域的需求稳定,预计在预测期内将占据最大的市场份额。单点雷射辅助装置(SPLS)因其减少疤痕和加快恢復时间,在一般外科手术中越来越受欢迎。医院正越来越多地采用先进的器械来提高效率并最大限度地降低手术风险。全球手术量的成长进一步巩固了SPLS在一般外科手术中的重要性。器械设计和人体工学方面的持续创新进一步强化了主导地位。
预计在预测期内,门诊手术中心(ASC)细分市场将呈现最高的复合年增长率。
预计在预测期内,门诊手术中心(ASC)领域将实现最高成长率,因为其经济高效的模式和较短的患者周转时间使其成为微创手术的理想场所。门诊手术中心正越来越多地采用先进的单点雷射手术(SPLS)设备,从而能够在传统医院之外进行复杂的手术。优惠的报销政策鼓励患者和医疗服务提供者转向门诊治疗。云端基础的监控和库存管理系统正在提高这些中心的营运效率。
预计亚太地区将在预测期内占据最大的市场份额。中国、印度和日本等国家医疗基础设施的快速扩张正在推动市场需求。各国政府正大力投资医院现代化和医疗设备製造。本地化生产措施和进口替代政策也为市场成长提供了支持。机器人辅助单点定位系统(SPLS)和人工智慧驱动的诊断技术在全部区域的应用正在加速。全球製造商与区域公司之间的策略合作正在促进技术转移和市场渗透。
预计北美地区在预测期内将呈现最高的复合年增长率。美国和加拿大在手术机器人、智慧手术室和人工智慧诊断技术方面处于主导地位。简化的监管流程正在促进下一代单点雷射手术系统(SPLS)工具的快速商业化。医院正在整合物联网和分析技术,以优化手术流程并改善患者预后。健全的报销机制正在支持微创技术的广泛应用。
According to Stratistics MRC, the Global Single-Port Laparoscopic Surgery Devices Market is accounted for $922.40 million in 2025 and is expected to reach $1867.26 million by 2032 growing at a CAGR of 10.6% during the forecast period. Single-port laparoscopic surgery devices are advanced tools used to conduct minimally invasive surgeries through one small incision, usually near the belly button. They combine imaging systems, access channels, and versatile instruments to allow surgeons to maneuver and operate inside the abdomen effectively. Their single-entry design reduces trauma, lowers pain and scarring, and supports faster healing, offering surgeons a controlled and streamlined way to perform complex procedures.
Increasing prevalence of chronic diseases
Healthcare providers are increasingly turning to minimally invasive approaches like SPLS to manage complex conditions with reduced trauma. Improvements in diagnostic imaging and early detection are expanding the pool of patients eligible for surgical interventions. Aging populations across both developed and emerging economies are further accelerating the need for efficient surgical devices. Robotic-assisted SPLS systems are enhancing precision, reducing complications, and shortening recovery times. The broader trend toward personalized medicine is also encouraging adoption of specialized laparoscopic instruments tailored to patient-specific needs.
Limited procedure standardization and data
Variability in techniques across hospitals and regions creates inconsistencies in patient outcomes. The lack of comprehensive long-term data on SPLS procedures slows clinical adoption and reimbursement approvals. Training requirements for surgeons remain high, adding to operational complexity and limiting scalability. Smaller device manufacturers struggle to establish credibility without robust clinical evidence and standardized guidelines. These factors collectively hinder rapid market penetration and slow the pace of innovation in SPLS technologies.
Robotic-assisted SPLS expansion
Advanced robotic systems provide enhanced dexterity, visualization, and precision compared to conventional laparoscopic tools. Hospitals are increasingly investing in robotic-assisted SPLS to improve surgical outcomes and reduce operative times. The combination of robotics and single-port access minimizes scarring and accelerates patient recovery. Emerging markets are adopting robotic SPLS as healthcare infrastructure modernizes and surgical volumes rise. Continuous R&D in robotics, AI, and imaging is expected to significantly expand the scope of SPLS applications.
Alternative minimally invasive techniques
The SPLS faces competition from other minimally invasive approaches such as multi-port laparoscopy and natural orifice transluminal endoscopic surgery (NOTES). These alternatives are often perceived as more established, with broader clinical data supporting their use. Hospitals may hesitate to invest in SPLS devices when existing techniques already deliver satisfactory outcomes. Cost considerations also play a role, as SPLS systems can be more expensive to implement. Patient preference and surgeon familiarity with traditional laparoscopic methods further limit SPLS adoption.
The pandemic disrupted surgical practices worldwide, delaying elective procedures and reducing demand for SPLS devices. Manufacturing and supply chain interruptions caused shortages in critical surgical equipment. However, the crisis accelerated digital adoption, with hospitals exploring tele-surgical platforms and remote diagnostics. Emergency regulatory approvals helped maintain access to essential surgical tools during peak disruption. Post-pandemic strategies now emphasize resilience, automation, and decentralized production to safeguard against future shocks.
The general surgery segment is expected to be the largest during the forecast period
The general surgery segment is expected to account for the largest market share during the forecast period, due to its broad application across procedures such as appendectomies, hernia repairs, and gallbladder removals drives consistent demand. SPLS devices are increasingly preferred in general surgery due to reduced scarring and faster recovery times. Hospitals are adopting advanced instruments to improve efficiency and minimize operative risks. Rising surgical volumes globally are reinforcing the importance of SPLS in general surgical practice. Continuous innovation in device design and ergonomics is further strengthening this segment's leadership.
The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate, due to their cost-efficient models and shorter patient turnaround times make them ideal settings for minimally invasive procedures. ASCs are increasingly equipped with advanced SPLS tools, enabling complex surgeries outside traditional hospitals. Favorable reimbursement policies are encouraging patients and providers to shift toward outpatient care. Cloud-based monitoring and inventory systems are enhancing operational efficiency in these centers.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapidly expanding healthcare infrastructure in countries like China, India, and Japan is fueling demand. Governments are investing heavily in hospital modernization and medical device manufacturing. Local production initiatives and import substitution policies are supporting market growth. Adoption of robotic-assisted SPLS and AI-driven diagnostics is accelerating across the region. Strategic collaborations between global manufacturers and regional players are strengthening technology transfer and market penetration.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR. The U.S. and Canada are leading in surgical robotics, smart operating rooms, and AI-enabled diagnostics. Streamlined regulatory pathways are encouraging faster commercialization of next-generation SPLS tools. Hospitals are integrating IoT and analytics to optimize surgical workflows and improve patient outcomes. Strong reimbursement frameworks support widespread adoption of minimally invasive technologies.
Key players in the market
Some of the key players in Single-Port Laparoscopic Surgery Devices Market include Medtronic, Intuitive Surgical, Johnson & Johnson, Olympus Corporation, Karl Storz, Stryker Corporation, Applied Medical, CONMED Corporation, Vicarious Surgical, Titan Medical, Advanced Surgical Concepts, NewView Surgical, Unimax Medical Systems, Sejong Medical, and Zhejiang Geyi Medical.
In October 2025, Johnson & Johnson MedTech announced the U.S. launch of INHANCE INTACT(TM), a proprietary complete instrumentation system specifically developed for subscapularis-sparing total shoulder arthroplasty1 (TSA), empowering surgeons to replace a damaged shoulder joint while keeping the shoulder muscle intact.
In October 2025, Olympus Corporation has entered into an international distribution agreement with the medical products business of U.S.-based W. L. Gore & Associates, Inc., a global materials science company that develops innovative products across diverse industries. The agreement allows Olympus to become the exclusive international distributor and have distribution rights of the GORE(R) VIABIL(R) Biliary Endoprosthesis for endoscopic placement.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.